Press Kit
Salvat at a glance
If you are a media professional and wish to receive more information, please send us an email at media@svt.com.
Salvat’s News and Press kit
Media
Salvat at a glance
Press Kit
What are we doing right now
News
Media
Salvat’s News and Press kit
Media
Salvat at a glance
Press Kit
What are we doing right now
News
Media
Laboratorios Salvat was represented at the 2018 BIO International Convention
/in Salvat International /by Carme LopezSalvat was part of the most important International Biotechnology congress, which was held at the Boston Convention Center (Massachusetts, USA) from July 4 to 7, 2018. BIO is a unique opportunity for companies in the pharmaceutical industry to establish relationships of scientific and commercial nature, as well as close deals and explore further collaborations with […]
Patronage of Laboratorios Salvat at the Choir of the Faculty of Pharmacy
/in Salvat Foundation /by adminsvtThe new agreement between the University of Barcelona and Salvat Laboratories has been signed so that they once again commit themselves to lend a hand in the form of patronage at the Choir of the Faculty of Pharmacy. Directed by Ahmet Süleyman Bilgin, with more than thirty vocalists, the choir has a wide musical repertoire, with […]
Pediapharm Announces the Commercial Launch of Otixal™ in Canada
/in Salvat International /by adminsvtNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Pediapharm Inc. (“Pediapharm” or the “Company”) (TSX VENTURE:PDP) is pleased to announce today the Canadian commercial launch of Otixal™ (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution for the treatment of acute otitis media with tympanostomy tubes (“AOMT”) in […]
Salvat launches Ekzem
/in Salvat Spain /by adminsvtWe present Ekzem®, the first and only medicinal product indicated for the treatment of eczematous otitis externa Up until the recent release of Ekzem®, launched by SALVAT this January 2017, there was no medicinal product in Spain specifically indicated for the treatment of eczematous otitis externa. Up until now, otorhinolaryngologists, primary care physicians and other […]
Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC Announce the Launch of OTOVEL® (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution
/in Salvat USA /by adminsvtBARCELONA, Spain and ATLANTA, Aug. 29, 2016 /PRNewswire/ — Laboratorios SALVAT S.A. (SALVAT) and Arbor Pharmaceuticals, LLC (Arbor) jointly announce the launch of OTOVEL® (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution, the first and only antibiotic and steroid combination ear drop available in sterile, preservative-free single-dose vials. OTOVEL® is owned by SALVAT, […]